Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-18

Clinical Trial Update: Multicentric Approval Study Trans-Duodenal Barrier for Typ 2 Diabetes With Obesity [NA]

View source ↗

Summary

A multicenter approval study for a Trans-Duodenal Barrier device targeting type 2 diabetes with obesity is announced, with participant recruitment not yet start…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trans-Duodenal Barrier

Snippet

Sponsor: Trans-Duodenal Concepts GmbH | Conditions: Typ 2 Diabetes, Obesity | NA | Status: NOT_YET_RECRUITING